Published in Cancer Weekly, November 3rd, 1997
A single injection of the drug, a synthetic human hormone called PEG-rHuMGDF, can triple the number of platelets received from each donor, said Lawrence T. Goodnough, M.D., professor of medicine and of pathology at the Washington University School of Medicine in St. Louis, Missouri.
"Platelets are precious, and this drug could help ease the shortage," he says. Goodnough, a lead researcher in a multicenter study of the drug, announced the findings at the annual American Association of Blood Banks meeting in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.